InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Heartflow, Inc.

HTFL Clue Score58
United States Fiscal year ends December CIK 0001464521
$49.74 +4.43% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $49.74 +51.23% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 8 Aug 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Revenue87.2Operating income−72.9Net income−95.7EPS, diluted−25.32Fiscal year 2024Revenue125.8 +44.3%Operating income−61.2Net income−96.4EPS, diluted−17.98Fiscal year 2025Revenue176.0 +39.9%Operating income−64.1Net income−116.8EPS, diluted−3.17
FY2023FY2024FY2025
Revenue 87.2 125.8 176.0
Growth +44.3% +39.9%
Operating income −72.9 −61.2 −64.1
Net income −95.7 −96.4 −116.8
Growth
EPS, diluted −25.32 −17.98 −3.17

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2023Gross margin66.6%Operating margin−83.6%Net margin−109.7%Free cash flow margin−94.7%Fiscal year 2024Gross margin75.1%Operating margin−48.7%Net margin−76.6%Free cash flow margin−58.3%Fiscal year 2025Gross margin76.8%Operating margin−36.4%Net margin−66.3%Free cash flow margin−33.5%
FY2023FY2024FY2025
Gross margin 66.6% 75.1% 76.8%
Operating margin −83.6% −48.7% −36.4%
Net margin −109.7% −76.6% −66.3%
Free cash flow margin −94.7% −58.3% −33.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow−76.4Capital expenditure−6.1Free cash flow−82.5Buybacks−0.2Fiscal year 2024Operating cash flow−69.0Capital expenditure−4.4Free cash flow−73.4Fiscal year 2025Operating cash flow−54.0Capital expenditure−5.0Free cash flow−59.0
FY2023FY2024FY2025
Operating cash flow −76.4 −69.0 −54.0
Capital expenditure −6.1 −4.4 −5.0
Free cash flow −82.5 −73.4 −59.0
Growth
Buybacks −0.2 n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2023Cash122.8Shareholders’ equity−777.6Fiscal year 2024Cash51.4Shareholders’ equity−859.5Fiscal year 2025Cash44.8Shareholders’ equity300.6
FY2023FY2024FY2025
Cash 122.8 51.4 44.8
Shareholders’ equity −777.6 −859.5 300.6

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
66.6% 75.1% 76.8%
−83.6% −48.7% −36.4%
−109.1% −76.6% −66.4%
−109.7% −76.6% −66.3%
−94.7% −58.3% −33.5%
Spending
41.1% 34.6% 36.9%
109.1% 89.1% 76.3%
7.0% 3.5% 2.9%
Returns
n/a n/a −38.8%
n/a −81.2% −32.5%
Balance and payout
n/a 176.6% 16.4%